Mon, December 8, 2008
Sun, December 7, 2008
Sat, December 6, 2008
Fri, December 5, 2008
Thu, December 4, 2008
Wed, December 3, 2008
[ Wed, Dec 03rd 2008 ] - Market Wire
Protherics PLC: Offer Update
Tue, December 2, 2008
Mon, December 1, 2008
Sun, November 30, 2008
Fri, November 28, 2008
Thu, November 27, 2008
Wed, November 26, 2008
Tue, November 25, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
HST Global Quarterly Update
Mon, November 24, 2008
Thu, November 20, 2008
Wed, November 19, 2008
Tue, November 18, 2008
Mon, November 17, 2008

Inspire Announces Webcast of Presentation at Piper Jaffray Conference


//health-fitness.news-articles.net/content/2008/ .. of-presentation-at-piper-jaffray-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, will present at the Piper Jaffray 20th Annual Health Care Conference Tuesday, December 2, 2008 at 9:30 am ET in New York City.

Also in conjunction with the conference, Benjamin R. Yerxa, Ph.D., Executive Vice President and Chief, Research and Development, will participate on a cystic fibrosis panel Wednesday, December 3, 2008 at 10:00 am ET.

The webcast of Dr. Shaffer's presentation will be available on Inspire's web site at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Elestat and Restasis are registered trademarks owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit [ www.inspirepharm.com ].


Publication Contributing Sources

Similar Health and Fitness Publications